Human cardiac stem cells with reduced notch signaling show enhanced therapeutic potential in a rat acute infarction model

Circulation Journal

Volumn 78, Issue 1, 2014, Pages 222-231

  Matsuda, Takenori ^a,b   Miyagawa, Shigeru ^a   Fukushima, Satsuki ^a   Kitagawa Sakakida, Satoru ^a   Akimaru, Hiroshi ^b   Horii Komatsu, Miki ^b   Kawamoto, Atsuhiko ^b   Saito, Atsuhiro ^c   Asahara, Takayuki ^b,d   Sawa, Yoshiki ^a,c  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b INSTITUTE OF BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

^c OSAKA UNIVERSITY HOSPITAL   (Japan)

^d TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiac stem cells; Cell culture; Notch signaling

Indexed keywords

ANGIOPOIETIN RECEPTOR; CELL NUCLEUS ANTIGEN; DEXAMETHASONE; GAMMA SECRETASE INHIBITOR; INTERLEUKIN 8; MYOSIN LIGHT CHAIN; NOTCH RECEPTOR; PROTEIN P21; PROTEIN P53; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR ETS 1; TRANSCRIPTION FACTOR HES 1; VASCULOTROPIN A;

ACUTE HEART INFARCTION; ADULT; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CASE REPORT; CELL DENSITY; CELL DIFFERENTIATION; CELL POPULATION; CELL PROLIFERATION; CHILD; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MIDDLE AGED; NONHUMAN; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; SMOOTH MUSCLE FIBER; STEM CELL TRANSPLANTATION; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADULT; ANIMALS; CELLS, CULTURED; CHILD; FEMALE; HETEROGRAFTS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; RATS; RATS, NUDE; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 84891067062     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-13-0534     Document Type: Article

References (35)

1. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, et al. Heart disease and stroke statistics: 2011 update. A report from the American Heart Association. Circulation 2011; 123: e18-e209, doi:10.1161/CIR.0b013e3182009701.
2. Yamauchi T, Miyata H, Sakaguchi T, Miyagawa S, Yoshikawa Y, Takeda K, et al. Coronary artery bypass grafting in hemodialysisdependent patients: Analysis of Japan Adult Cardiovascular Surgery Database. Circ J 2012; 76: 1115-1120.
3. Bearzi C, Rota M, Hosoda T, Tillmanns J, Nascimbene A, De Angelis A, et al. Human cardiac stem cells. Proc Natl Acad Sci USA 2007; 104: 14068-14073.
4. Chimenti I, Smith RR, Li TS, Gerstenblith G, Messina E, Giacomello A, et al. Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circ Res 2010; 106: 971-980.
5. Choi SH, Jung SY, Kwon SM, Baek SH. Perspectives on stem cell therapy for cardiac regeneration: Advances and challenges. Circ J 2012; 76: 1307-1312.
6. Bolli R, Chugh AR, D'Amario D, Loughran JH, Stoddard MF, Ikram S, et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): Initial results of a randomised phase 1 trial. Lancet 2011; 378: 1847-1857.
7. D'Amario D, Fiorini C, Campbell PM, Goichberg P, Sanada F, Zheng H, et al. Functionally competent cardiac stem cells can be isolated from endomyocardial biopsies of patients with advanced cardiomyopathies. Circ Res 2011; 108: 857-861.
8. Bartosh TJ, Wang Z, Rosales AA, Dimitrijevich SD, Roque RS. 3Dmodel of adult cardiac stem cells promotes cardiac differentiation and resistance to oxidative stress. J Cell Biochem 2008; 105: 612-623.
9. Tang YL, Zhu W, Cheng M, Chen L, Zhang J, Sun T, et al. Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression. Circ Res 2009; 104: 1209-1216.
10. Messina E, De Angelis L, Frati G, Morrone S, Chimenti S, Fiordaliso F, et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 2004; 95: 911-921.
11. Tomita Y, Matsumura K, Wakamatsu Y, Matsuzaki Y, Shibuya I, Kawaguchi H, et al. Cardiac neural crest cells contribute to the dormant multipotent stem cell in the mammalian heart. J Cell Biol 2005; 170: 1135-1146.
12. Yang L, Soonpaa MH, Adler ED, Roepke TK, Kattman SJ, Kennedy M, et al. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 2008; 453: 524-528.
13. Bu L, Jiang X, Martin-Puig S, Caron L, Zhu S, Shao Y, et al. Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature 2009; 460: 113-117.
14. Sekiya I, Larson BL, Smith JR, Pochampally R, Cui JG, Prockop DJ. Expansion of human adult stem cells from bone marrow stroma: Conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells 2002; 20: 530-541.
15. Yanagisawa M, Mukai A, Shiomi K, Song SY, Hashimoto N. Community effect triggers terminal differentiation of myogenic cells derived from muscle satellite cells by quenching Smad signaling. Exp Cell Res 2011; 317: 221-233.
16. Boni A, Urbanek K, Nascimbene A, Hosoda T, Zheng H, Delucchi F, et al. Notch1 regulates the fate of cardiac progenitor cells. Proc Natl Acad Sci USA 2008; 105: 15529-15534.
17. Chen VC, Stull R, Joo D, Cheng X, Keller G. Notch signaling respecifies the hemangioblast to a cardiac fate. Nat Biotechnol 2008; 26: 1169-1178.
18. Kwon C, Qian L, Cheng P, Nigam V, Arnold J, Srivastava D. A regulatory pathway involving Notch1/beta-catenin/Isl1 determines cardiac progenitor cell fate. Nat Cell Biol 2009; 11: 951-957.
19. Obi S, Masuda H, Shizuno T, Sato A, Yamamoto K, Ando J, et al. Fluid shear stress induces differentiation of circulating phenotype endothelial progenitor cells. Am J Physiol Cell Physiol 2012; 303: C595-C606.
20. Gomes SA, Rangel EB, Premer C, Dulce RA, Cao Y, Florea V, et al. S-nitrosoglutathione reductase (GSNOR) enhances vasculogenesis by mesenchymal stem cells. Proc Natl Acad Sci USA 2013; 110: 2834-2839.
21. Imanishi Y, Saito A, Komoda H, Kitagawa-Sakakida S, Miyagawa S, Kondoh H, et al. Allogenic mesenchymal stem cell transplantation has a therapeutic effect in acute myocardial infarction in rats. J Mol Cell Cardiol 2008; 44: 662-671.
22. Iwasaki H, Kawamoto A, Ishikawa M, Oyamada A, Nakamori S, Nishimura H, et al. Dose-dependent contribution of CD34-positive cell transplantation to concurrent vasculogenesis and cardiomyogenesis for functional regenerative recovery after myocardial infarction. Circulation 2006; 113: 1311-1325.
23. Bray SJ. Notch signalling: A simple pathway becomes complex. Nat Rev Mol Cell Biol 2006; 7: 678-689.
24. Urbanek K, Cabral-da-Silva MC, Ide-Iwata N, Maestroni S, Delucchi F, Zheng H, et al. Inhibition of notch1-dependent cardiomyogenesis leads to a dilated myopathy in the neonatal heart. Circ Res 2010; 107: 429-441.
25. Zakharova L, Nural-Guvener H, Gaballa MA. Cardiac explant-derived cells are regulated by Notch-modulated mesenchymal transition. PLoS One 2012; 7: e37800, doi:10.13731/journal.pone.0037800.
26. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003; 114: 763-776.
27. Fischer KM, Cottage CT, Wu W, Din S, Gude NA, Avitabile D, et al. Enhancement of myocardial regeneration through genetic engineering of cardiac progenitor cells expressing Pim-1 kinase. Circulation 2009; 120: 2077-2087.
28. Lanner F, Sohl M, Farnebo F. Functional arterial and venous fate is determined by graded VEGF signaling and notch status during embryonic stem cell differentiation. Arterioscler Thromb Vasc Biol 2007; 27: 487-493.
29. Tan KS, Tamura K, Lai MI, Veerakumarasivam A, Nakanishi Y, Ogawa M, et al. Molecular pathways governing development of vascular endothelial cells from ES/iPS Cells. Stem Cell Rev 2013 June 14, doi:10.1007/s12015-013-9450-7 [Epub ahead of print].
30. Bearzi C, Leri A, Lo Monaco F, Rota M, Gonzalez A, Hosoda T, et al. Identification of a coronary vascular progenitor cell in the human heart. Proc Natl Acad Sci USA 2009; 106: 15885-15890.
31. Shahi P, Seethammagari MR, Valdez JM, Xin L, Spencer DM. Wnt and Notch pathways have interrelated opposing roles on prostate progenitor cell proliferation and differentiation. Stem Cells 2011; 29: 678-688.
32. Segers VF, Lee RT. Stem-cell therapy for cardiac disease. Nature 2008; 451: 937-942.
33. Dimmeler S, Burchfield J, Zeiher AM. Cell-based therapy of myocardial infarction. Arterioscler Thromb Vasc Biol 2008; 28: 208-216.
34. Coric V, van Dyck CH, Salloway S, Andreasen N, Brody M, Richter RW, et al. Safety and tolerability of the gamma-secretase inhibitor avagacestat in a Phase 2 study of mild to moderate alzheimer disease. Arch Neurol 2012; 69: 1430-1440.
35. Alshammary S, Fukushima S, Miyagawa S, Matsuda T, Nishi H, Saito A, et al. Impact of cardiac stem cell sheet transplantation on myocardial infarction. Surg Today 2013 March 5, doi:10.1007/s00595-013-0528-2 [Epub ahead of print].